Ethnic Bridging

California Clinical Trials (CCT) is the world leader in Japanese Bridging Studies. We help major drug companies gather their Japanese data right here in the U.S., saving time and development costs.

We have pioneered ICH bridging and ethnic sensitivity study development for these companies. In addition to advising on regulatory issues with the FDA, we write research protocols and conduct Phase I clinical trials that have proven acceptable to the Japanese regulatory authority. We utilize Japanese subjects, meeting strict intrinsic and extrinsic criteria for ethnicity living in Los Angeles.

Related Links